Form 4 for TARA Protara Therapeutics, Inc.
Accepted 2022-01-05 00:00:00 ET · period of report 2022-01-03 · accession 0001209191-22-001725 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-05 | 2022-01-03 | TARA | Zummo Jacqueline | Chf Scientific Ops Off | A - Grant | $0.00 | +14.1K | 83.6K | +20% | $0 |
| D | 2022-01-05 | 2022-01-03 | TARA | Zummo Jacqueline | Chf Scientific Ops Off | A - Grant | $0.00 | +84.8K | 84.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-03 | A | A | 14,100 | $0.00 | 83,560 | D | — | — | (F1) The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one-third installments on the first, second and third anniversaries of January 3, 2022. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-01-03 | A | A | 84,800 | $0.00 | 84,800 | D | $6.90 · — to 2032-01-02 | 84,800 Common Stock | (F2) 25% of the shares vest on the one year anniversary of January 3, 2022 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date. |